Abstract: Patients suffering from Hydrocephalus show an increased accumulation of cerebrospinal fluid, which needs to be drained into another body compartment by an implanted shunt. To prevent from over-drainage, which sometimes still occurs despite improvements in shunt technology, a possible future shunt could contain sensors and supervise the ventricular size electrically. This work approaches this and presents the in vitro study of a drainage catheter with integrated bioimpedance evaluation capabilities.
Introduction
Most Hydrocephalus patients suffer from an imbalance between production and resorption of cerebrospinal fluid (CSF), increased ventricles, filled with CSF ( Figure 1 ) resulting in increased intracranial pressure. Depending on the kind of Hydrocephalus, patients can be treated by implanting a shunt with an overpressure valve, which drains CSF from the ventricles into another body compartment, whenever the pressure along the shunt exceeds its opening pressure. The right opening pressure according to the current patient's needs has to be chosen in order to successfully treat him. In the case of under-drainage not sufficient CSF is drained and during over-drainage ventricles can even collapse to so called slit ventricles. In both cases the patient suffers from headache. In order to determine the right drainage, ventricular size can be controlled by expensive and time consuming imaging techniques like magnetic resonance imaging (MRI). Untreated Hydrocephalus patients can suffer from incontinence, headache, dementia, disturbance of gait or even fall into coma. Due to the development of shunts the outlook for hydrocephalus patients could be improved but problems like slit ventricles still remain [1] . In a 10-years experience Mpakopoulou et al. reported shunt revision rate varies between 20 and 40 % depending of the shunt type used [2] . These results motivate for improvements in shunt technology. A bioimpedance sensor integrated into the ventricular catheter of the shunt would enable continuous monitoring of the actual ventricular shunt size and adapt the drainage of an electromechanical shunt. Linninger et al. showed already impressive results with a self-made catheter with 4
lateral ventricles parenchyma

Δs
Figure 1: MRI of the lateral ventricles electrodes attached to it, which were evaluated in simulations, in test rigs and in animal experiments [3] , [4] . The following work focuses on the measurement options with several electrodes by integrating thin electrode arrays onto flexible commercially-available ventricular catheters. The performance of a 6-contact device is evaluated in vitro with respect to its electrical properties.
Methods
A detailed technical description of the electrode fabrication procedure will be addressed in a future publication. Here, we will restrict to a basic description to understand its functionality. A medical grade silicone rubber-based array is wrapped around a commercially available drainage catheter (Ø 2 mm). It is designed with three pairs of electrode contacts (width: 750 µm each electrode) with a distance of 1.2 cm between them. The outer pairs are positioned just before and after the perforated section of the catheter (s. Figure 2) . To maintain the flexibility of the catheter without compromising the wiring during mechanical loads, wide meander tracks of 150 µm width were designed, permitting multiple bending cycles up to 90 degrees in all direc- Figure 2 : Bioimpedance electrodes integrated on a commercially available ventricular catheter tions. To allow fluid extraction on different catheter types, the perforation of the rubber consists of multiple punctures with a diameter of 500 µm randomly spread over all unwired areas. Biocompatibility is not a concern, given that all materials used, namely 12.5 µm thick platinum metal for the electrode contacts and embedded wiring, medical grade silicone rubber for the insulation and MP35N for wires are materials with a history of medical approval and application in multiple commercially available implantable devices.
To represent artificial parenchyma and characterize the electrode arrays two agarose-gel phantoms with different hollow volumes but with same electrical conductance (0.172 S/m) were manufactured. The cavities were filled with artificial CSF: distilled water mixed with NaCl to obtain the conductance of CSF (2 S/m). The cavities represent normal (15 ml) and enlarged (300 ml) lateral ventricles. The catheter was placed in the middle and at the border of the compartment in order to compare the influence of the position on the measurement.
In another measurement setup two of the electrode pairs were surrounded by artificial CSF and one by artificial parenchyma (s. Figure 3) . The electrodes on the catheter were connected with a precision LCR meter E4980A to induce small currents of up to 5 mA within a frequency sweep of 1 kHz to 1 MHz. Different configurations for the inner measurement electrodes were tested.
Results
There was an increase of up to 60 % in electrical impedance when measuring in the middle of the normal sized compared to the enlarged ventricles at 1 kHz. When moving the ventricular catheter to the wall of the enlarged ventricles (1 cm away) a change of 3 % could be detected in impedance measurements. U m1 and U m2 differed in value when not all 3 pairs were surrounded by CSF. Wobbling of the catheter as it would presumably occur during walking of the patient did not change the results. Possible measurent scenarios with a bioimpedance catheter in normal sized (left) and enlarged ventricles (right)
Discussion and Conclusions
From these results the conclusion can be drawn that this presented ventricular bioimpedance catheter can detect a change in ventricular size. Changes of the ventricular position from the middle to the ventricular wall also induces an impedance change but 23 fold less. As further information from the additional pair of electrodes (6 instead of 4 electrodes) the diminishment in ventricular size can be detected, if the last electrode pair from the ventricular tip is surrounded by parenchyma instead of CSF. For in vivo experiments, current has to be reduced to minimum 10 µA.
